{"entity":{"type":"insider","cik":"0001304815","url":"/insider/0001304815","json_url":"/insider/0001304815.json","name":"IGUCHI KIMI","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":33,"n_filings":14,"first":"2014-07-23","last":"2019-03-01","span_basis":"filed_date"},"name_variants":[{"name":"IGUCHI KIMI","source":"filing","n_filings":14,"first_seen":"2014-07-23","last_seen":"2019-03-01"}],"transactions":[{"id":8404342,"accession":"0001562180-19-001529","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-19-001529","line_url":"/filing/0001562180-19-001529#line-1","is_derivative":false,"issuer_cik":"0001304815","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001304815","owner_cik":"0001304815","owner_name":"IGUCHI KIMI","owner_display_name":"IGUCHI KIMI","owner_url":"/insider/0001304815","role":"Officer (CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25563.0,"shares_display":"25,563","price_per_share":156.93,"price_display":"156.93","price_state":"stated","total_value":4011601.59,"total_display":"4,011,601.59","total_whole":"4,011,602","shares_owned_after":1413.0,"shares_owned_after_display":"1,413","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-01","filed_date":"2019-03-01","scope":"insider"},{"id":6077896,"accession":"0001562180-18-002039","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-18-002039","line_url":"/filing/0001562180-18-002039","is_derivative":false,"issuer_cik":"0001304815","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001304815","owner_cik":"0001304815","owner_name":"IGUCHI KIMI","owner_display_name":"IGUCHI KIMI","owner_url":"/insider/0001304815","role":"Officer (CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12782.0,"shares_display":"12,782","price_per_share":144.20389062744485,"price_display":"144.20","price_state":"stated","total_value":1843214.13,"total_display":"1,843,214.13","total_whole":"1,843,214","shares_owned_after":25663.0,"shares_owned_after_display":"25,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-26","filed_date":"2018-04-27","scope":"insider","n_lines":5},{"id":6793582,"accession":"0001562180-18-001968","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001562180-18-001968","line_url":"/filing/0001562180-18-001968","is_derivative":false,"issuer_cik":"0001304815","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001304815","owner_cik":"0001304815","owner_name":"IGUCHI KIMI","owner_display_name":"IGUCHI KIMI","owner_url":"/insider/0001304815","role":"Officer (CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11018.0,"shares_display":"11,018","price_per_share":140.7523906335088,"price_display":"140.75","price_state":"stated","total_value":1550809.84,"total_display":"1,550,809.84","total_whole":"1,550,810","shares_owned_after":41545.0,"shares_owned_after_display":"41,545","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-25","filed_date":"2018-04-25","scope":"insider","n_lines":3},{"id":6793570,"accession":"0001562180-18-001968","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001562180-18-001968","line_url":"/filing/0001562180-18-001968","is_derivative":false,"issuer_cik":"0001304815","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001304815","owner_cik":"0001304815","owner_name":"IGUCHI KIMI","owner_display_name":"IGUCHI KIMI","owner_url":"/insider/0001304815","role":"Officer (CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":142.837,"price_display":"142.84","price_state":"stated","total_value":714185.0,"total_display":"714,185.00","total_whole":"714,185","shares_owned_after":51863.0,"shares_owned_after_display":"51,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-24","filed_date":"2018-04-25","scope":"insider","n_lines":5},{"id":6793549,"accession":"0001562180-18-001968","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-18-001968","line_url":"/filing/0001562180-18-001968","is_derivative":false,"issuer_cik":"0001304815","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001304815","owner_cik":"0001304815","owner_name":"IGUCHI KIMI","owner_display_name":"IGUCHI KIMI","owner_url":"/insider/0001304815","role":"Officer (CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12135.0,"shares_display":"12,135","price_per_share":144.48304655953854,"price_display":"144.48","price_state":"stated","total_value":1753301.77,"total_display":"1,753,301.77","total_whole":"1,753,302","shares_owned_after":58799.0,"shares_owned_after_display":"58,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-23","filed_date":"2018-04-25","scope":"insider","n_lines":6},{"id":4680017,"accession":"0001562180-17-000234","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-17-000234","line_url":"/filing/0001562180-17-000234#line-1","is_derivative":false,"issuer_cik":"0001304815","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001304815","owner_cik":"0001304815","owner_name":"IGUCHI KIMI","owner_display_name":"IGUCHI KIMI","owner_url":"/insider/0001304815","role":"Officer (CFO, Secretary and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":53.92,"price_display":"53.92","price_state":"stated","total_value":539200.0,"total_display":"539,200.00","total_whole":"539,200","shares_owned_after":66498.0,"shares_owned_after_display":"66,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-13","filed_date":"2017-01-13","scope":"insider"},{"id":2462516,"accession":"0001562180-16-003576","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-16-003576","line_url":"/filing/0001562180-16-003576#line-1","is_derivative":false,"issuer_cik":"0001304815","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001304815","owner_cik":"0001304815","owner_name":"IGUCHI KIMI","owner_display_name":"IGUCHI KIMI","owner_url":"/insider/0001304815","role":"Officer (CFO, Secretary and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":51.77,"price_display":"51.77","price_state":"stated","total_value":207080.0,"total_display":"207,080.00","total_whole":"207,080","shares_owned_after":75739.0,"shares_owned_after_display":"75,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-17","filed_date":"2016-11-18","scope":"insider"},{"id":2688990,"accession":"0001562180-16-003468","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-16-003468","line_url":"/filing/0001562180-16-003468#line-1","is_derivative":false,"issuer_cik":"0001304815","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001304815","owner_cik":"0001304815","owner_name":"IGUCHI KIMI","owner_display_name":"IGUCHI KIMI","owner_url":"/insider/0001304815","role":"Officer (CFO, Secretary and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":50.59,"price_display":"50.59","price_state":"stated","total_value":75885.0,"total_display":"75,885.00","total_whole":"75,885","shares_owned_after":79739.0,"shares_owned_after_display":"79,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-11","filed_date":"2016-11-14","scope":"insider"},{"id":2572459,"accession":"0001562180-16-003136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-16-003136","line_url":"/filing/0001562180-16-003136#line-1","is_derivative":false,"issuer_cik":"0001304815","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001304815","owner_cik":"0001304815","owner_name":"IGUCHI KIMI","owner_display_name":"IGUCHI KIMI","owner_url":"/insider/0001304815","role":"Officer (CFO, Secretary and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":40.93,"price_display":"40.93","price_state":"stated","total_value":102325.0,"total_display":"102,325.00","total_whole":"102,325","shares_owned_after":81239.0,"shares_owned_after_display":"81,239","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-07","filed_date":"2016-09-09","scope":"insider"},{"id":2572352,"accession":"0001562180-16-002792","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-16-002792","line_url":"/filing/0001562180-16-002792#line-1","is_derivative":false,"issuer_cik":"0001304815","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001304815","owner_cik":"0001304815","owner_name":"IGUCHI KIMI","owner_display_name":"IGUCHI KIMI","owner_url":"/insider/0001304815","role":"Officer (CFO, Secretary and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":49.55,"price_display":"49.55","price_state":"stated","total_value":247750.0,"total_display":"247,750.00","total_whole":"247,750","shares_owned_after":83739.0,"shares_owned_after_display":"83,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-12","filed_date":"2016-07-14","scope":"insider"},{"id":2688701,"accession":"0001562180-16-001291","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-16-001291","line_url":"/filing/0001562180-16-001291#line-1","is_derivative":false,"issuer_cik":"0001304815","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001304815","owner_cik":"0001304815","owner_name":"IGUCHI KIMI","owner_display_name":"IGUCHI KIMI","owner_url":"/insider/0001304815","role":"Officer (CFO, Secretary and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary and Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":176.0,"shares_display":"176","price_per_share":49.56,"price_display":"49.56","price_state":"stated","total_value":8722.56,"total_display":"8,722.56","total_whole":"8,723","shares_owned_after":84739.0,"shares_owned_after_display":"84,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-31","filed_date":"2016-01-07","scope":"insider"},{"id":8222736,"accession":"0001562180-15-000734","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-15-000734","line_url":"/filing/0001562180-15-000734#line-1","is_derivative":false,"issuer_cik":"0001304815","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001304815","owner_cik":"0001304815","owner_name":"IGUCHI KIMI","owner_display_name":"IGUCHI KIMI","owner_url":"/insider/0001304815","role":"Officer (CFO, Secretary and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":54.84,"price_display":"54.84","price_state":"stated","total_value":164520.0,"total_display":"164,520.00","total_whole":"164,520","shares_owned_after":84563.0,"shares_owned_after_display":"84,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-08","filed_date":"2015-09-09","scope":"insider"},{"id":8834509,"accession":"0001562180-15-000659","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-15-000659","line_url":"/filing/0001562180-15-000659","is_derivative":false,"issuer_cik":"0001304815","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001304815","owner_cik":"0001304815","owner_name":"IGUCHI KIMI","owner_display_name":"IGUCHI KIMI","owner_url":"/insider/0001304815","role":"Officer (CFO, Secretary and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":67.606335,"price_display":"67.61","price_state":"stated","total_value":270425.34,"total_display":"270,425.34","total_whole":"270,425","shares_owned_after":88801.0,"shares_owned_after_display":"88,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-10","filed_date":"2015-08-11","scope":"insider","n_lines":3},{"id":8785180,"accession":"0001562180-15-000560","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-15-000560","line_url":"/filing/0001562180-15-000560#line-1","is_derivative":false,"issuer_cik":"0001304815","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001304815","owner_cik":"0001304815","owner_name":"IGUCHI KIMI","owner_display_name":"IGUCHI KIMI","owner_url":"/insider/0001304815","role":"Officer (CFO, Secretary and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO, Secretary and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Secretary and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":68.0,"price_display":"68.00","price_state":"stated","total_value":272000.0,"total_display":"272,000.00","total_whole":"272,000","shares_owned_after":91563.0,"shares_owned_after_display":"91,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-06","filed_date":"2015-07-06","scope":"insider"},{"id":8853880,"accession":"0001562180-15-000466","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-15-000466","line_url":"/filing/0001562180-15-000466#line-1","is_derivative":false,"issuer_cik":"0001304815","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001304815","owner_cik":"0001304815","owner_name":"IGUCHI KIMI","owner_display_name":"IGUCHI KIMI","owner_url":"/insider/0001304815","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":80.1,"price_display":"80.10","price_state":"stated","total_value":200250.0,"total_display":"200,250.00","total_whole":"200,250","shares_owned_after":95563.0,"shares_owned_after_display":"95,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-08","filed_date":"2015-06-08","scope":"insider"},{"id":6444287,"accession":"0001209191-14-048712","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-048712","line_url":"/filing/0001209191-14-048712#line-1","is_derivative":false,"issuer_cik":"0001304815","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001304815","owner_cik":"0001304815","owner_name":"IGUCHI KIMI","owner_display_name":"IGUCHI KIMI","owner_url":"/insider/0001304815","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":108000.0,"total_display":"108,000.00","total_whole":"108,000","shares_owned_after":98063.0,"shares_owned_after_display":"98,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-23","filed_date":"2014-07-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":33,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":31,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":33},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001597553","name":"Sage Therapeutics, Inc.","url":"/issuer/0001597553","role":"Officer (CFO & Treasurer)","n_filings":14,"first_seen":"2014-07-23","last_seen":"2019-03-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001304815","retrieved_at":"2026-08-23T02:50:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}